Publications by authors named "Elodie Autrusseau"

Biomarkers that could predict the evolution of the graft in transplanted patients and that could allow to adapt the care of the patients would be an invaluable tool. Additionally, certain biomarkers can be target of treatments and help to stratify patients. Potential effective biomarkers have been identified but still need to be confirmed.

View Article and Find Full Text PDF
Article Synopsis
  • Allogeneic bone marrow transplantation (BMT) is a common treatment for blood diseases, but it can cause a serious side effect called graft-versus-host disease (GVHD).
  • This study explored a new treatment using anti-CD45RC antibodies that can help prevent GVHD by reducing harmful T cells and increasing helpful T cells.
  • The results showed that this treatment was safe and effective in lab tests, suggesting it could be a promising option to manage GVHD without stopping the body’s ability to fight tumors.
View Article and Find Full Text PDF

Autoimmune regulator (AIRE) deficiency in humans induces a life-threatening generalized autoimmune disease called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), and no curative treatments are available. Several models of AIRE-deficient mice have been generated, and although they have been useful in understanding the role of AIRE in central tolerance, they do not reproduce accurately the APECED symptoms, and thus there is still a need for an animal model displaying APECED-like disease. We assessed, in this study, the potential of the rat as an accurate model for APECED.

View Article and Find Full Text PDF

Both CD4 and CD8 Tregs play a critical role in the control of immune responses and immune tolerance; however, our understanding of CD8 Tregs is limited while they are particularly promising for therapeutic application. We report here existence of highly suppressive human CD8CD45RC Tregs expressing Foxp3 and producing IFNγ, IL-10, IL-34, and TGFβ to mediate their suppressive activity. We demonstrate that total CD8CD45RC Tregs can be efficiently expanded in the presence of anti-CD3/28 mAbs, high-dose IL-2 and IL-15 and that such expanded Tregs efficiently delay GVHD and human skin transplantation rejection in immune humanized mice.

View Article and Find Full Text PDF

Rat and human CD4 and CD8 Tregs expressing low levels of CD45RC have strong immunoregulatory properties. We describe here that human CD45 isoforms are nonredundant and identify distinct subsets of cells. We show that CD45RC is not expressed by CD4 and CD8 Foxp3 Tregs, while CD45RA/RB/RO are.

View Article and Find Full Text PDF

Viral invasion into a host is initially recognized by the innate immune system, mainly through activation of the intracellular cytosolic signaling pathway and coordinated activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-κB) transcription factors that promote type I interferon gene induction. The TANK-binding Kinase 1 (TBK1) phosphorylates and activates IRF3. Here, we show that Optineurin (Optn) dampens the antiviral innate immune response by targeting the deubiquitinating enzyme CYLD to TBK1 in order to inhibit its enzymatic activity.

View Article and Find Full Text PDF

Invariant natural killer T (iNKT) cells promote immune responses to various pathogens, but exactly how iNKT cells control antiviral responses is unclear. Here, we showed that iNKT cells induced tissue-specific antiviral effects in mice infected by lymphocytic choriomeningitis virus (LCMV). Indeed, iNKT cells inhibited viral replication in the pancreas and liver but not in the spleen.

View Article and Find Full Text PDF